Bionovate Technologies Corp
- Jurisdiction
Switzerland - ISIN
US09074V2025 (BIIO )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
1
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
0
/ 7
Profile
Bionovate Technologies Corp., a medical device company, focuses on developing automated treatment for age spots. Read full profile
Stock price
Fundamentals
- Net revenue
€0.00 - Gross margin
0.0% - EBIT
€0.00 - EBIT margin
0.0% - Net income
€0.00 - Net margin
0.0%
Statement period: - (published )
Dividends
No dividend payouts